Claudia Pessoa Selected Research

Therapeutics

5/2022	The Isoflavanoid (+)-PTC Regulates Cell-Cycle Progression and Mitotic Spindle Assembly in a Prostate Cancer Cell Line.
1/2021	EGFR targeting for cancer therapy: Pharmacology and immunoconjugates with drugs and nanoparticles.
1/2021	CRISPR/Cas9 small promoter deletion in H19 lncRNA is associated with altered cell morphology and proliferation.
1/2021	Immunoconjugates for Cancer Targeting: A Review of Antibody-Drug Conjugates and Antibody-Functionalized Nanoparticles.
12/2019	Epidrugs: targeting epigenetic marks in cancer treatment.
12/2018	Natural products as new antimitotic compounds for anticancer drug development.
2/2013	Overview of the therapeutic potential of piplartine (piperlongumine).
1/2012	Development of nanoaptamers using a mesoporous silica model labeled with (99m)tc for cancer targeting.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claudia Pessoa Research Topics

Disease

45	Neoplasms (Cancer) 05/2024 - 11/2007
6	Melanoma (Melanoma, Malignant) 07/2023 - 11/2007
6	Leukemia 01/2020 - 02/2010
5	Carcinoma (Carcinomatosis) 01/2020 - 09/2012
4	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 09/2012
3	Prostatic Neoplasms (Prostate Cancer) 05/2022 - 03/2014
3	Carcinogenesis 01/2021 - 10/2010
2	Sarcoma 180 01/2021 - 08/2010
2	Colorectal Neoplasms (Colorectal Cancer) 02/2020 - 01/2020
2	Infections 03/2012 - 07/2002
2	Chromosome Aberrations (Chromosome Abnormalities) 12/2011 - 05/2008
1	Papillomavirus Infections 12/2024
1	Phototoxic Dermatitis (Phototoxicity) 05/2024
1	Breast Neoplasms (Breast Cancer) 05/2024
1	Adenocarcinoma 03/2023
1	Starvation 01/2023
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Hypoxia (Hypoxemia) 02/2020
1	Chronic Disease (Chronic Diseases) 09/2019
1	Dyslipidemias (Dyslipidemia) 09/2019
1	Hemorrhage 09/2019
1	Inflammation (Inflammations) 09/2019

Drug/Important Bio-Agent (IBA)

7	beta-lapachoneIBA 03/2023 - 11/2007
5	quinone (benzoquinone)IBA 02/2023 - 10/2016
4	QuinonesIBA 02/2023 - 11/2007
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2007
4	Volatile Oils (Essential Oils)IBA 09/2019 - 12/2011
3	NaphthoquinonesIBA 01/2021 - 05/2010
2	AntioxidantsIBA 07/2023 - 01/2020
2	2,2'- azino- di- (3- ethylbenzothiazoline)- 6- sulfonic acid (ABTS)IBA 07/2023 - 01/2020
2	Fluorescent Dyes (Fluorescent Probes)IBA 03/2023 - 01/2023
2	Monoclonal AntibodiesIBA 01/2021 - 01/2021
2	Immunoconjugates (Immunoconjugate)IBA 01/2021 - 01/2021
2	AlkaloidsIBA 01/2021 - 07/2002
2	HydrazonesIBA 01/2021 - 01/2020
2	AntibodiesIBA 01/2021 - 03/2012
2	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 01/2014
2	Isoniazid (Ftivazide)FDA LinkGeneric 12/2016 - 01/2014
2	TubulinIBA 10/2013 - 06/2012
1	hydrogen sulfite (bisulfite)IBA 12/2024
1	phthalocyanineIBA 05/2024
1	SolutionsIBA 05/2024
1	Liposomes (Liposome)IBA 05/2024
1	Therapeutic UsesIBA 05/2024
1	chloroaluminum phthalocyanineIBA 05/2024
1	Dichlorodiphenyldichloroethane (DDD)IBA 01/2024
1	phthalic acid (phthalate)IBA 07/2023
1	arabinogalactanIBA 03/2023
1	ImidazolesIBA 03/2023
1	Cytotoxins (Cytolysins)IBA 03/2023
1	RoscovitineIBA 01/2023
1	AndrogensIBA 05/2022
1	Panitumumab (Vectibix)FDA Link 01/2021
1	Cetuximab (Erbitux)FDA Link 01/2021
1	LipidsIBA 01/2021
1	nimotuzumabIBA 01/2021
1	necitumumabIBA 01/2021
1	Long Noncoding RNAIBA 01/2021
1	H19 long non-coding RNAIBA 01/2021
1	AntigensIBA 01/2021
1	pyrimidineIBA 01/2021
1	pyrazoleIBA 01/2021
1	NitrogenIBA 10/2020
1	BromidesIBA 08/2020
1	Biocompatible Materials (Biomaterials)IBA 08/2020
1	LigandsIBA 02/2020
1	Tirapazamine (SR 4233)IBA 02/2020
1	secnidazoleIBA 02/2020
1	ThiosemicarbazonesIBA 02/2020
1	Methylene Chloride (Dichloromethane)IBA 01/2020
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 01/2020
1	ethyl acetateIBA 01/2020
1	Methanol (Carbinol)IBA 01/2020
1	diphenyl (biphenyl)IBA 01/2020
1	3- (4,5- dimethyl- 2- thiazolyl)- 2,5- diphenyl- 2H- tetrazolium bromideIBA 01/2020
1	Betulinic AcidIBA 01/2020
1	QuinoxalinesIBA 01/2020
1	6- hydroxy- 2,5,7,8- tetramethylchroman- 2- carboxylic acid (Trolox)IBA 01/2020
1	Sulfonic AcidsIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 09/2019
1	Alkaline PhosphataseIBA 09/2019
1	AlbuminsIBA 09/2019
1	Complex MixturesIBA 07/2019
1	Vinca AlkaloidsIBA 12/2018
1	Taxoids (Taxanes)IBA 12/2018
1	lawsoneIBA 05/2018
1	Acetates (Acetic Acid Esters)FDA Link 05/2018
1	Capsules (Microcapsules)IBA 10/2017
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 10/2017
1	Glutathione Disulfide (GSSG)FDA LinkGeneric 01/2017
1	Glutathione (Reduced Glutathione)IBA 01/2017
1	4,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA 01/2017
1	Antitubercular AgentsIBA 12/2016

Therapy/Procedure

8	Therapeutics 05/2022 - 01/2012
1	Photochemotherapy (Photodynamic Therapy) 05/2024
1	Precision Medicine 03/2023
1	Drug Therapy (Chemotherapy) 01/2021
1	Phytotherapy (Herbal Therapy) 01/2020
1	Injections 09/2019